National Agency for Food and Drug Administration and Control

  • Home
  • Nigeria
  • Abuja
  • National Agency for Food and Drug Administration and Control

National Agency for Food and Drug Administration and Control The Official Page of NAFDAC Nigeria
We are totally committed to Safeguarding the Health of the Nation

In accordance with the enabling laws, NAFDAC is authorised to:

• Regulate and control the importation, exportation, manufacture, advertisement, distribution, sale and use of regulated products.

• Conduct appropriate tests and ensure compliance with standard specifications.

• Undertake appropriate investigation of the production premises and raw materials of regulated products.

• Compile standa

rd specifications, regulations, and guidelines for the production, importation, exportation, sale and distribution of regulated products.

• Control the exportation and issue quality certification of regulated products intended for export.

• Establish and maintain relevant laboratories for the performance of its functions.

• Ensure that the use of narcotic drugs and psychotropic substances are limited to medical and scientific use only.

• Undertake the registration of food, drugs, medical devices, bottled water and chemicals.

• Undertake inspection of imported regulated products.

• Pronounce on the quality and safety of regulated products after appropriate analysis. We are committed to ensure that we take a holistic approach in the discharge of our regulatory functions.

ℹ️ NAFDAC is strengthening regulatory oversight of blood and blood products in Nigeria to promote quality, safety, trace...
13/08/2026

ℹ️ NAFDAC is strengthening regulatory oversight of blood and blood products in Nigeria to promote quality, safety, traceability and patient protection across the blood transfusion chain.

This development marks an important step in strengthening Nigeria’s health system and aligning blood and blood products regulation with global best practices.

Read the press release ⬇️ to learn about NAFDAC’s regulatory preparedness, the new institutional structures supporting this mandate, and the Agency’s commitment to working with stakeholders to ensure safe, quality-assured and efficacious blood and blood products for Nigerians.

12/08/2026

🔎 Can you spot a substandard or falsified product?

In this episode of , Hannatu Odekunle from our Post Marketing Surveillance Directorate takes us through some key signs to look out for when verifying the authenticity and quality of a regulated product.

From packaging and labelling to NAFDAC Registration Numbers, batch numbers, dates, manufacturer details and tamper-proof seals, knowing what to check can help you make safer choices and protect yourself from potentially harmful products.

▶️ Watch, learn and share.

NAFDAC, Denmark Strengthen Regulatory Cooperation on Medicines, Food Safety and Public HealthNAFDAC has received a deleg...
12/08/2026

NAFDAC, Denmark Strengthen Regulatory Cooperation on Medicines, Food Safety and Public Health

NAFDAC has received a delegation from the Embassy of Denmark for a stakeholder engagement aimed at strengthening regulatory cooperation and technical collaboration in healthcare, medicines regulation, pharmaceutical supply chains, food safety and public health.

The Discussions focused on outstanding regulatory matters concerning Danish-linked pharmaceutical products, regulatory reliance, Good Distribution and Storage Practices, supply-chain traceability, post-marketing surveillance, laboratory verification and cold-chain management.

Both sides also explored opportunities for collaboration in public health education, digital health solutions, capacity building and technical cooperation.

NAFDAC highlighted the importance of regulatory reliance, noting that credible assessment reports from trusted regulatory authorities can support and potentially expedite product assessments where all required documentation is available.

Both parties reaffirmed their commitment to sustained dialogue and practical cooperation to strengthen regulatory systems and enhance the protection of public health in Nigeria.

07/08/2026

Protect breastfeeding. Support informed choices.

In this episode of , learn how NAFDAC protects, promotes and supports breastfeeding through the implementation and enforcement of the Breast-milk Substitutes (BMS) Code.



▶️ Watch, learn and share.

Public Alert No. 037/2026.Alert on suspected counterfeit Pulmicort® (Budesonide) Inhalation Suspension https://bit.ly/4w...
07/08/2026

Public Alert No. 037/2026.
Alert on suspected counterfeit Pulmicort® (Budesonide) Inhalation Suspension


https://bit.ly/4wNeYg5

NAFDAC is informing the public of the detection of a suspected counterfeit medicinal product found in the Nigerian market that infringes on the approved marketing authorisation for Pulmicort® (Budesonide) manufactured by AstraZeneca. The information was provided to NAFDAC by AstraZeneca following market surveillance activities.

AstraZeneca reported that the identified suspected falsified product is marketed as “Ulmicort 0.5 mg/ml Inhalation Suspension”, bearing a name that closely resembles its registered product Pulmicort®, and may mislead healthcare professionals and patients.

Genuine Pulmicort® (budesonide) is an inhaled corticosteroid prescribed as a maintenance treatment to prevent asthma symptoms (such as wheezing and shortness of breath) and as prophylactic therapy.

NAFDAC is investigating the distribution and source of the suspected counterfeit products. All zonal directors and state coordinators have been directed to conduct surveillance and mop-up activities to identify and remove any counterfeit products from circulation in Nigeria.

Consumers and healthcare professionals are advised to report any suspicion of the sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office, call 0800-162-3322, or send an email to [email protected]

Public Alert No. 036/2026.Alert on suspected counterfeit products mimicking Forxiga® (Dapagliflozin) https://bit.ly/4fUD...
06/08/2026

Public Alert No. 036/2026.
Alert on suspected counterfeit products mimicking Forxiga® (Dapagliflozin)


https://bit.ly/4fUDLr4

NAFDAC is informing the public of the detection of suspected counterfeit medicinal products found in the Nigerian market that infringe on the approved marketing authorisation of Forxiga® (dapagliflozin) manufactured by AstraZeneca.

AstraZeneca notified NAFDAC following market surveillance activities which identified products bearing names closely resembling Forxiga® and mimicking the AstraZeneca logo. The product names “Forzigar” and “Foziga” closely resemble Forxiga®, thereby creating a potential risk of confusion among healthcare professionals and patients. The products also imitate the AstraZeneca brand identity and logo.

Genuine Forxiga (dapagliflozin) is primarily prescribed for three major conditions: to improve blood sugar control in Type 2 diabetes, to reduce cardiovascular death and hospitalisations in heart failure, and to slow the progression of chronic kidney disease.

It is also important to note the details of the genuine product:
• Product Name: Forxiga®
• Generic Name: Dapagliflozin
• Dosage Form: Film-coated tablets
• Marketing Authorisation Holder: AstraZeneca

NAFDAC is investigating the distribution and source of the suspected counterfeit products. All zonal directors and state coordinators have been directed to conduct surveillance and mop-up activities to identify and remove any counterfeit products from circulation in Nigeria.

Consumers and healthcare professionals are advised to report any suspicion of the sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office, call 0800-162-3322, or send an email to [email protected]

06/08/2026

How did the ban on sachet alcohol and alcoholic beverages packaged in PET bottles below 200ml come about?

In this excerpt from her interview on Channels Television, our Director-General, Prof. Mojisola Adeyeye, provides a detailed timeline of the policy, explaining how the Federal Government, regulatory agencies, industry trade groups, and other stakeholders have been actively engaged since December 2018 to implement the phased ban.

▶️ Watch the video to understand the background and the collaborative process.

04/08/2026

Every packaged food has a story to tell, and that story begins with the food label.

In the first episode of , our food safety expert, Abubakar Tanimu Umar from the Food Safety and Applied Nutrition Directorate, explains why reading food labels is one of the simplest ways to make safer and healthier food choices.

Before you buy a packaged food, remember to:
✅ Check the date marking
✅ Read the ingredient list
✅ Review the Nutrition Information Panel
✅ Confirm the NAFDAC Registration Number

A few seconds spent reading the label can help you make informed decisions for yourself and your family.

▶️ Watch, learn and share.

Public Alert No. 035/2026.Alert on the marketing and sale of unregistered Menofix Compositionhttps://bit.ly/4wqnaC5 NAFD...
04/08/2026

Public Alert No. 035/2026.
Alert on the marketing and sale of unregistered Menofix Composition
https://bit.ly/4wqnaC5



NAFDAC is alerting the public about the marketing and sale of unregistered Menofix Composition. NAFDAC received a complaint concerning the marketing and sale of Menofix Capsules. The complainant also raised concerns regarding possible liver-related adverse effects associated with some of the ingredients contained in the product.

Following investigation, it was established that the complaint product, Menofix, is not registered with NAFDAC.

Further review found that the product being marketed differs from similarly named products already registered by the Agency. Two registered products with a similar name are Menofix Herbal Capsule (NAFDAC Reg. No. A7-103321L) and Menofix Powder (NAFDAC Reg. No. A7-103342L), both registered under the Herbal and Nutraceuticals category and manufactured by Gudugudu Herbal Worldwide Enterprises.

Menofix by Pure Eve is marketed as a hormone-free, vegetarian-friendly multivitamin and herbal supplement designed to help women navigate the physical and hormonal shifts of perimenopause and menopause.
It appears to be widely available for over-the-counter purchase, including through online channels and open retail outlets.

Product details:
• Product Name: Menofix Capsules
• Regulatory Status: Not registered with NAFDAC
• Marketed by: PureEve (as stated in the investigation findings)

Monitoring is ongoing to get hold of the distribution line. All NAFDAC zonal directors and state coordinators have been instructed to conduct surveillance and remove the unregistered product if found within their zones and states.

Healthcare professionals and consumers are advised to report any suspicion of the sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office, call 0800-162-3322, or send an email to [email protected]

NAFDAC has joined a landmark international research consortium awarded a £3.7 million grant by the UK's Medical Research...
03/08/2026

NAFDAC has joined a landmark international research consortium awarded a £3.7 million grant by the UK's Medical Research Council to advance innovative technologies for detecting substandard, degraded, and falsified vaccines.

The initiative will enhance vaccine post-marketing surveillance in Nigeria through advanced screening technologies, routine laboratory testing, and evidence-based research to strengthen vaccine quality assurance.

Read the full press release ⬇️ to learn how this collaboration will reinforce Nigeria's regulatory systems, protect public health, and build greater confidence in the nation's vaccine supply.

Address

Plot 2032, Olusegun Obasanjo Way
Abuja
900287

Opening Hours

Monday 08:00 - 16:00
Tuesday 08:00 - 16:00
Wednesday 08:00 - 16:00
Thursday 08:00 - 16:00
Friday 08:00 - 16:00

Telephone

+2349097630506

Website

Alerts

Be the first to know and let us send you an email when National Agency for Food and Drug Administration and Control posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to National Agency for Food and Drug Administration and Control:

Shortcuts

Share

Category